Two-pore domain K⁺ channels: evidence for TWIK-2 in blood pressure regulation.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 21876073)

Published in Hypertension on August 29, 2011

Authors

Asif R Pathan, Nancy J Rusch

Articles cited by this

Disruption of K(2P)6.1 produces vascular dysfunction and hypertension in mice. Hypertension (2011) 1.49

Articles by these authors

Smooth muscle cell plasticity: fact or fiction? Circ Res (2012) 2.18

Upregulation of L-type Ca2+ channels in mesenteric and skeletal arteries of SHR. Hypertension (2002) 1.49

High blood pressure upregulates arterial L-type Ca2+ channels: is membrane depolarization the signal? Circ Res (2004) 1.47

Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats. J Hypertens (2002) 1.46

Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels. J Physiol (2003) 1.44

Regulation of arterial tone by KV1 potassium channels. Circ Res (2005) 1.43

Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications. Vascul Pharmacol (2006) 1.31

New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure. Microcirculation (2002) 1.22

Upregulation of vascular calcium channels in neonatal piglets with hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2008) 1.11

Freshly isolated bovine coronary endothelial cells do not express the BK Ca channel gene. J Physiol (2002) 1.04

Nitration and functional loss of voltage-gated K+ channels in rat coronary microvessels exposed to high glucose. Diabetes (2004) 0.97

Intracellular Ca2+ silences L-type Ca2+ channels in mesenteric veins: mechanism of venous smooth muscle resistance to calcium channel blockers. Circ Res (2009) 0.94

Photoacoustic and photothermal detection of circulating tumor cells, bacteria and nanoparticles in cerebrospinal fluid in vivo and ex vivo. J Biophotonics (2013) 0.94

Starring TREK-1: the next generation of vascular K+ channels. Circ Res (2007) 0.92

A serotonin-induced N-glycan switch regulates platelet aggregation. Sci Rep (2013) 0.92

The β3 subunit contributes to vascular calcium channel upregulation and hypertension in angiotensin II-infused C57BL/6 mice. Hypertension (2012) 0.91

Postsynaptic density-95 scaffolding of Shaker-type K⁺ channels in smooth muscle cells regulates the diameter of cerebral arteries. J Physiol (2011) 0.89

U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance. Am J Physiol Heart Circ Physiol (2005) 0.87

The cellular distribution of serotonin transporter is impeded on serotonin-altered vimentin network. PLoS One (2009) 0.86

BK channels in cardiovascular disease: a complex story of channel dysregulation. Am J Physiol Heart Circ Physiol (2009) 0.85

Design of mutant beta2 subunits as decoy molecules to reduce the expression of functional Ca2+ channels in cardiac cells. J Pharmacol Exp Ther (2008) 0.85

Loss of cerebrovascular Shaker-type K(+) channels: a shared vasodilator defect of genetic and renal hypertensive rats. Am J Physiol Heart Circ Physiol (2009) 0.84

Inositol 1,4,5-trisphosphate (IP3) receptor up-regulation in hypertension is associated with sensitization of Ca2+ release and vascular smooth muscle contractility. J Biol Chem (2013) 0.83

Disrupting calcium channel expression to lower blood pressure: new targeting of a well-known channel. Mol Interv (2006) 0.82

Delivery of ion channel genes to treat cardiovascular diseases. Trans Am Clin Climatol Assoc (2008) 0.81

NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs. Bioorg Med Chem Lett (2009) 0.80

Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets. Pulm Circ (2012) 0.80

Protein kinase A-phosphorylated KV1 channels in PSD95 signaling complex contribute to the resting membrane potential and diameter of cerebral arteries. Circ Res (2014) 0.79

Gender Differences in Cardiovascular Drugs. Cardiovasc Drugs Ther (2015) 0.79

Quantitative measurement of acetyl fentanyl and acetyl norfentanyl in human urine by LC-MS/MS. Anal Chem (2014) 0.78

Serotonin uptake rates in platelets from angiotensin II-induced hypertensive mice. Health (Irvine Calif) (2013) 0.77

High-conductance, Ca(2+) -activated K+ channels: altered expression profiles in aging and cardiovascular disease. Mol Interv (2009) 0.76